APA

Mujtaba M. G., Flowers L. O., Patel C. B., Patel R. A., Haider M. I. & Johnson H. M. (20051213). Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Mujtaba Mustafa G, Flowers Lawrence O, Patel Chintak B, Patel Ravi A, Haider Mohammad I and Johnson Howard M. 20051213. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Mujtaba M. G., Flowers L. O., Patel C. B., Patel R. A., Haider M. I. and Johnson H. M. (20051213). Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Mujtaba Mustafa G, Flowers Lawrence O, Patel Chintak B, Patel Ravi A, Haider Mohammad I and Johnson Howard M. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form. : Journal of immunology (Baltimore, Md. : 1950). 20051213.